4D Molecular Therapeutics Inc
NASDAQ:FDMT

Watchlist Manager
4D Molecular Therapeutics Inc Logo
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Watchlist
Price: 10.84 USD -0.73% Market Closed
Market Cap: 619.4m USD

Intrinsic Value

The intrinsic value of one FDMT stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.84 USD, 4D Molecular Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

FDMT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
4D Molecular Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

FDMT looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether FDMT usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about FDMT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is FDMT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for 4D Molecular Therapeutics Inc.

Explain Valuation
Compare FDMT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about FDMT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
4D Molecular Therapeutics Inc

Current Assets 312.4m
Cash & Short-Term Investments 305.1m
Other Current Assets 7.3m
Non-Current Assets 111.6m
Long-Term Investments 67.2m
PP&E 35.1m
Other Non-Current Assets 9.4m
Current Liabilities 37.1m
Accounts Payable 6.9m
Accrued Liabilities 25.7m
Other Current Liabilities 4.5m
Non-Current Liabilities 17.9m
Other Non-Current Liabilities 17.9m
Efficiency

Free Cash Flow Analysis
4D Molecular Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
4D Molecular Therapeutics Inc

Revenue
120k USD
Operating Expenses
-230.5m USD
Operating Income
-230.4m USD
Other Expenses
21.2m USD
Net Income
-209.2m USD
Fundamental Scores

FDMT Profitability Score
Profitability Due Diligence

4D Molecular Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

4D Molecular Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

FDMT Solvency Score
Solvency Due Diligence

4D Molecular Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

4D Molecular Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FDMT Price Targets Summary
4D Molecular Therapeutics Inc

Wall Street analysts forecast FDMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FDMT is 33.77 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

Lowest
Price Target
17.17 USD
58% Upside
Average
Price Target
33.77 USD
212% Upside
Highest
Price Target
47.25 USD
336% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

4D Molecular Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for FDMT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

FDMT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one FDMT stock?

The intrinsic value of one FDMT stock under the Base Case scenario is hidden USD.

Is FDMT stock undervalued or overvalued?

Compared to the current market price of 10.84 USD, 4D Molecular Therapeutics Inc is hidden .

Back to Top